Anti-tumor properties of lymphocytes activated by the oxidizing mitogens

J. Wang, Manikkam Suthanthiran, A. Walle, M. Lagman, R. Schwartz, V. Murthi, A. Novogrodsky, K. H. Stenzel

Research output: Contribution to journalArticle

2 Citations (Scopus)


Human peripheral blood mononuclear cells when activated with the oxidizing mitogens, neuraminidase/galactose oxidase or sodium periodate, express cytolytic activity for freshly isolated tumor cells and for a variety of cell lines, including NK-resistant solid tumor lines. Normal lymphoid cells are not targets for cytotoxicity and do not inhibit lysis of susceptible targets mediated by the oxidizing mitogen-activated mononuclear cells. The cytotoxic response is rapidly generated and reaches peak levels at 48 hr. The oxidizing mitogens induce expression of IL 2 receptors on peripheral blood mononuclear cells. Combined treatment of cells with IL 2 and the oxidizing mitogens results in a marked enhancement of cytotoxicity. Enhancement is achieved at levels of IL 2 that alone result in minimal generation of cytotoxic cells. Growth of a human renal cancer cell line in nude mice was inhibited when the renal cancer cells were injected together with oxidizing mitogen-activated human mononuclear cells. These studies indicate that oxidizing mitogen-activated cells provide a potentially valuable source of material for the adoptive immunotherapy of tumors.

Original languageEnglish
Pages (from-to)4735-4739
Number of pages5
JournalJournal of Immunology
Issue number12
Publication statusPublished - 27 Aug 1986
Externally publishedYes


ASJC Scopus subject areas

  • Immunology

Cite this

Wang, J., Suthanthiran, M., Walle, A., Lagman, M., Schwartz, R., Murthi, V., Novogrodsky, A., & Stenzel, K. H. (1986). Anti-tumor properties of lymphocytes activated by the oxidizing mitogens. Journal of Immunology, 136(12), 4735-4739.